"Prevention of Coronary Restenosis". Cardiology in Review. 7 (4): 219-231. doi:10.1097/00045415-199907000-00014. PMID 10423674. ...

February 1988). "Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative ... 15 March 2008). "A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery ... 2008). "A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions ( ... 14 March 2009). "A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple ...

the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single ... Thus, coronary artery stents were created to prevent restenosis after balloon dilation. There are three types of stents: bare- ... Coronary Artery Stent Drug-Eluting Stent Antiplatelet drug Endothelial Progenitor Cells Coronary Artery Disease Interventional ... A dual therapy stent is a coronary artery stent that combines the technology of an antibody-coated stent and a drug-eluting ...

... is used in drug-eluting coronary stents as an immunosuppressant to prevent restenosis. Abbott Vascular produce an ...

"Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis". The American ... Lopid Coronary Angiography Trial". Atherosclerosis. 139 (1): 49-56. doi:10.1016/S0021-9150(98)00053-7. PMID 9699891. de Maat MP ... Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (May 1996). "Progression of coronary atherosclerosis is ... such as progressive coronary atherosclerosis. The -1171 5A/6A variant has also been associated with congenital anomalies such ...

"Anti-HLA antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy ... Woollett, IF; Pinney, S; Magnano, AR (2005). "Balloon dilatation of coronary sinus spasm during placement of a biventricular ... Pinney, SP; Wasserman, HS (2002). "Anterior myocardial infarction, acute aortic dissection and anomalous coronary artery". ...

... reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. ...

"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis". ... In the coronary circulation, angiography of coronary artery responses to vasoactive agents may be used to test for endothelial ... It has shown an 80% sensitivity and 86% specificity to diagnose coronary artery disease when compared against the gold standard ... This results suggests that this peripheral test reflects the physiology of the coronary endothelium. Since NO maintains low ...

Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation. ...

... is used as an antiproliferative agent for the prevention of restenosis (recurrent narrowing) of coronary and ... May 2001). "Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis". ... Paclitaxel drug-eluting stents for coronary artery placement are sold under the trade name Taxus by Boston Scientific in the ...

Neointimal hyperplasia is the major cause of restenosis after percutaneous coronary interventions such as stenting or ... Angioplasty Drug-eluting stent Restenosis Stent Kleinedler, James J; Foley, John D; Orchard, Elysse A; Dugas, Tammy R (2012). " ... P radioactive β-emitting stents were used in coronary artery lesions with results showing inhibition of neointimal hyperplasia ... Shah, P. K (2003). "Inflammation, Neointimal Hyperplasia, and Restenosis: As the Leukocytes Roll, the Arteries Thicken". ...

Therefore, IRE has been suggested as preventive treatment for coronary artery re-stenosis after percutaneous coronary ...

... and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary ... Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo- ... in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo- ... Prophylaxis of acute thrombotic events after percutaneous transluminal coronary angioplasty (PTCA) Reviparin is a low molecular ...

2001). "Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis". ... could prevent restenosis. His research interests include delivery of stem cells to the heart for repair of myocardial ... His clinical interests include high risk and complex coronary intervention, treatment of hypertrophic cardiomyopathy, including ...

2004). "IL-1 cluster genes and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: a prospective, ...

... , or ABT-578, was originally used on Abbott's coronary stent platforms to reduce early inflammation and restenosis; ... Restenosis is typically described by clinical trials in a binary approach, otherwise known as "binary restenosis" or just " ... development of thrombosis which impedes the efficiency of coronary stents, haemorrhagic and restenosis complications are ... The first human coronary stent implantation was first performed in 1986 by Puel et al. However, there are complications ...

Controlled amounts of 90Sr and 89Sr can be used in treatment of bone cancer, and to treat coronary restenosis via vascular ...

Since then, rapamycin has also shown to be effective for preventing coronary artery re-stenosis and for the treatment of ... "Device profile of the Resolute Onyx Zotarolimus eluting coronary stent system for the treatment of coronary artery disease: ... In 2003, the U.S. Food and Drug Administration approved sirolimus-eluting coronary stents, which are used in patients with ... Zotarolimus is an immunosuppressant used in coronary drug-eluting stents. The second generation of mTOR inhibitors is known as ...

... he is known to have established a radiation therapy department at the hospital for the treatment of coronary restenosis. Later ... Gambhir, known to have specialized in non-surgical coronary interventional techniques, is reported to have performed over ... he is reported to have performed over 10,000 coronary interventions. The Government of India awarded him the fourth highest ...

... can be used in the treatment of coronary in-stent restenosis, in which a catheter is placed inside blood vessels ... for the treatment of coronary in-stent restenosis. The dose rate of brachytherapy refers to the level or 'intensity' with which ... "Guidelines for Percutaneous Coronary Interventions: the Task Force for Percutaneous Coronary Interventions of the European ... In treating In-stent restenosis (ISR) Drug Eluting stents (DES) have been found to be superior to Intracoronary Brachytherapy ( ...

The antiproliferative effect of sirolimus has also been used in conjunction with coronary stents to prevent restenosis in ... A sirolimus-eluting coronary stent was marketed by Cordis, a division of Johnson & Johnson, under the tradename Cypher. However ... "Cypher Sirolimus-eluting Coronary Stent". Cypher Stent. Archived from the original on 27 April 2003. Retrieved 1 April 2008. ... The sirolimus is formulated in a polymer coating that affords controlled release through the healing period following coronary ...

... to prevent the occurrence of coronary artery restenosis. The first application of this approach for use of stents evolved from ... This will dilate the diameter of the coronary artery and keep it fixed in this phase so that more blood flows through the ... Drug-eluting stents (DES) are used by interventional cardiologists, operating on patients with coronary artery disease. The ... Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation, Biomaterials 23 (2002), ...

... use of radioactive source to inhibit restenosis) Coronary intravascular lithotripsy (IVL) The angioplasty procedure usually ... "Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery ... Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing of the coronary arteries of the ... Coronary angioplasty, also known as percutaneous transluminal coronary angioplasty (PTCA), because it is done through the skin ...

That stent was used as a scaffold to prevent a vessel from closing and to avoid restenosis in coronary surgery-a condition ... The first use of a coronary stent is typically attributed to Jacques Puel [fr] and Ulrich Sigwart, who implanted a stent into a ... To further reduce the incidence of restenosis, the drug-eluting stent was introduced in 2003. Research has led to general stent ... Coronary Stent Drug-Eluting Stents - Angioplasty.Org Cardiovascular and Interventional Radiological Society of Europe The ...

... which was specifically developed for the treatment of coronary in-stent restenosis (ISR) in September 2022. Subsequently, the ... in coronary arteries. Furthermore, the company has recently acquired its fourth IDE approval for the treatment of superficial ... and balloons used in the treatment of coronary and peripheral artery diseases. Founded in 2008 by Manish Doshi, the company is ...

Clinically significant CAV may require percutaneous coronary interventions for focal disease, but the likelihood of restenosis ... Similar to coronary artery disease in those who have not had a heart transplant, risk factors to CAV include high blood ... In addition to the same risk factors for coronary artery disease due to the build up of plaque, CAV is more likely to occur if ... This can be seen to affect the whole length of the coronary arteries and often the smaller arteries. Calcification does not ...

... provide a less durable treatment for atherosclerosis and be more prone to restenosis relative to vascular bypass or coronary ... Coronary angioplasty is indicated for coronary artery disease such as unstable angina, NSTEMI, STEMI and spontaneous coronary ... coronary arteries of the heart found in coronary heart disease. These stenotic segments of the coronary arteries arise due to ... A percutaneous coronary intervention (PCI), or coronary angioplasty with stenting, is a non-surgical procedure used to improve ...

Association of CMTM5 gene expression with the risk of in-stent restenosis in patients with coronary artery disease after drug- ... and/or one of its CMTM5 proteins may promote atherosclerosis-based coronary artery disease and the stenosis of coronary artery ... Liu TF, Lin T, Ren LH, Li GP, Peng JJ (December 2020). "[Association between CMTM5 gene and coronary artery disease and the ... The same research group similarly studied 124 hospitalized patients who had in place a coronary artery stent. They found that ...

... by SmithKline Beecham in partnership with Kissei for prevention of restenosis after percutaneous transluminal coronary ... September 2002). "Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial". Circulation. 106 (10): ...

... is indicated for the prevention of strokes and when combined with aspirin, for people with a new coronary stent to ... Stent Anticoagulation Restenosis Study Investigators". The New England Journal of Medicine. 339 (23): 1665-1671. doi:10.1056/ ... Research initially showed that it was useful for preventing strokes and coronary stent occlusions. However, because of its rare ... December 2014). "2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report ...